
OBHSA
CAS No. 1404508-27-5
OBHSA( —— )
Catalog No. M37082 CAS No. 1404508-27-5
OBHSA(Oxabicycloheptane sulfonamide) is a novel selective estrogen receptor depressant (SERD) that can be used to study breast cancer.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 296 | Get Quote |
![]() ![]() |
5MG | 459 | Get Quote |
![]() ![]() |
10MG | 657 | Get Quote |
![]() ![]() |
25MG | 994 | Get Quote |
![]() ![]() |
50MG | 1371 | Get Quote |
![]() ![]() |
100MG | 1773 | Get Quote |
![]() ![]() |
500MG | 3537 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameOBHSA
-
NoteResearch use only, not for human use.
-
Brief DescriptionOBHSA(Oxabicycloheptane sulfonamide) is a novel selective estrogen receptor depressant (SERD) that can be used to study breast cancer.
-
DescriptionOBHSA(Oxabicycloheptane sulfonamide) is a novel selective estrogen receptor depressant (SERD) that can be used to study breast cancer.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
TargetEstrogen Receptor/ERR
-
RecptorEstrogen/progestogen Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1404508-27-5
-
Formula Weight547.54
-
Molecular FormulaC27H24F3NO6S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESS(N(CC(F)(F)F)C1=CC=C(OC)C=C1)(=O)(=O)[C@@H]2[C@]3(C(=C([C@](O3)(C2)[H])C4=CC=C(O)C=C4)C5=CC=C(O)C=C5)[H]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog



related products
-
Lasofoxifene Tartrat...
Lasofoxifene Tartrate?is a third-generation non-steroidal selective estrogen receptor modulator.
-
Astragaloside IV
Astragaloside IV is generally considered to be the primary active ingredient in Astragalus extract,an herbal extract which has been famous for literally thousands of years for its anti-aging properties.
-
Elacestrant dihydroc...
Elacestrant (RAD-1901) is a novel, orally bioavailable small-molecule selective estrogen receptor degrader (SERD).